Introduction: Injury is recognized as a major health problem in most high and low-income countries. Rafsanjan is considered as one of the accident-prone areas in Kerman province. 
Objective: To study the epidemiology of traffic accidents in the Rafsanjan city.
Methods: This cross-sectional study was conducted, by using the data from the Emergency Department (ED) of Aliebn Abitaleb Hospital in Rafsanjan city. The population included all people who had had a traffic accident in the city of Rafsanjan from March 21, 2014 through February 18, 2015. The sample included those who had been injured and transferred to the ED of Aliebn Abitaleb Hospital. Data were analyzed using Chi-square, independent-samples t-test, and logistic regression. SPSS software version 19 was used for data analysis. P< 0.05 was considered statistically significant.
Results: Age, gender and location of accident, had significant association with the number of mortalities (p=0.02), and other results of this study suggest that there was a significant relationship between the status of the injured and the gender (p<0.001), the accident location (p<0.001), and the type of injury (p<0.001).
Conclusion: The rate of accidents in one year in Rafsanjan city was high. Moreover, young people and motorcyclists had most accidents. Teaching the laws and regulations to the people of the city, is the most effective method in reducing accidents and mortality.


Keywords: Epidemiology, Traffic accident, Rafsanjan


» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/6859
womens nike shoesMens Flynit Trainers

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.


To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here


Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.


The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:


TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: